For early and mid-stage life sciences companies, the timeline between major milestones can feel impossibly long. You’re not ready to announce funding or the data isn’t ready. There’s that awkward in-between phase when it feels like there’s nothing to say. But that’s exactly when you need to be visible.
Most companies go silent between milestones, waiting for the next funding announcement or clinical readout before they’ll justify reaching out to media, updating their website or posting on LinkedIn. Meanwhile, their competitors who understand strategic communications are building relationships, shaping narratives and staying visible.
Momentum isn’t built with announcements. It’s built in the quiet phases between them.
Lead With Perspective, Not News
You don’t need a press release to have something worth saying. What you need is a point of view on what’s happening in your therapeutic area right now. Maybe there’s a regulatory shift, or an investor concern that keeps coming up, or some misconception your team keeps hearing about. Whatever it is, write about it.
The FDA is changing how it thinks about rare disease approvals. Gene therapy companies are navigating new regulatory pathways. Whatever’s happening in your area of focus right now, there’s probably an angle worth exploring.
If you’re in gene therapy or rare disease, for example, these trends matter and your take on them matters. A thoughtful LinkedIn post explaining what these changes mean for your approach positions your team as informed and engaged, while others in the space who chose the silent route remain invisible.
Not All Progress Is Binary
Companies often think communications is only important for major milestones, but progress happens constantly, and most of it isn’t flashy. You hired a new Chief Medical Officer with deep expertise in your indication? That signals momentum. Secured a partnership with a leading academic center? That’s validation. Presented at a conference? You’re advancing the science. Won an industry award or grant? Recognition matters.
None of this is press release-worthy in the traditional sense, but it’s LinkedIn-worthy and website-worthy because it shows your company is moving. If stakeholders only see funding announcements from you, you’re training them to think you only exist when you’re raising money.
Build Relationships When You’re Not Asking for Anything
The best time to reach out to a reporter is before you have news. Journalists covering your space are constantly looking for sources who understand the landscape, people who can explain trends, provide context and offer informed takes. If the first time you contact a reporter is to pitch your Series B, you’re just another company asking for coverage.
But if you’ve been helpful before, if you’ve answered their questions about regulatory trends, connected them with other experts or provided thoughtful commentary, then you’ve built something. When you do have news, they’re more likely to pay attention.
The same works with investors, partners and advisors. Stay visible, share insights, be useful. Then when it’s time for a real conversation, you’re not starting from scratch.
Your Website Shouldn’t Look Stale
Go look at your website right now and check when you last updated it. If a potential investor or partner visits and the most recent update is from six months ago, the message is clear: not much is happening here. Your website and LinkedIn should show that your company is active and moving forward. That doesn’t mean constant press releases, just signs of life.
Update your “News” section with industry commentary. Add team members when you hire them. Post about conferences, collaborations and publications. Share your take on regulatory or scientific developments.
Even a monthly blog post keeps things from looking dormant, because static websites signal static companies.
Prepare for When the Quiet Is Over
Here’s what happens when you go silent for six months then suddenly announce a funding round. Reporters don’t know who you are. Investors see your name for the first time. Your LinkedIn post gets minimal engagement because you haven’t been building an audience.
But if you’ve been consistently visible, sharing perspectives, building relationships and demonstrating progress, then when you do have major news, it lands differently. Journalists know your story. Investors have been watching. Your network amplifies your announcement instead of scrolling past it.
Strategic communications during the quiet phase builds the foundation so that when you have something major to say, people are ready to listen.
If your last LinkedIn post was three months ago announcing a funding round, you’re telling people you only show up when you have news. That’s not a communications strategy. That’s a press release distribution list. Momentum doesn’t take breaks between milestones, and neither should your communications.
If you’re a life sciences company navigating the space between funding rounds, clinical readouts, or regulatory milestones, we help you stay visible when it matters most. From strategic LinkedIn content and media relationship-building to website refreshes and thought leadership positioning, we work with biotech and pharma companies to maintain momentum in the quiet phases.
Let’s start a conversation about how consistent, strategic communications can keep your company moving forward all year round.
